Here are five highlights:
1. Direct sales were $43.6 million, a 10 percent increase compared to the second quarter of 2016.
2. Double digit growth was reported in RTI Surgical’s spine, surgical specialties and cardiothoracic direct business segments.
3. Commercial revenues were $28.6 million, a 2 percent increase compared to second quarter of 2016 results.
4. RTI Surgical’s adjusted earnings were $8.3 million or 11 percent of second quarter revenues.
5. From these results, RTI Surgical expects full year revenues to be between $274 million and $280 million.
More articles on devices and implants:
DePuy Synthes & Medical Enterprises Distribution to co-market automated THA technology: 6 points
Bioventus names new CFO, general counsel: 4 takeaways
Mazor Robotics, K2M, Globus Medical & more: 12 device company notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
